Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Tong CC, Au KH, Ngan RK, Chow SM, Cheung FY, Fu YT, Au JS, Law SC.

Radiat Oncol. 2011 May 21;6:53. doi: 10.1186/1748-717X-6-53.

2.

Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.

Laskar SG, Baijal G, Murthy V, Chilukuri S, Budrukkar A, Gupta T, Agarwal JP.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e180-6. doi: 10.1016/j.clon.2012.07.001. Epub 2012 Aug 3.

PMID:
22862908
3.

Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.

Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):115-26.

PMID:
9300746
4.

Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.

Sakata K, Aoki Y, Karasawa K, Hasezawa K, Muta N, Nakagawa K, Terahara A, Onogi Y, Sasaki Y, Akanuma A.

Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1059-64.

PMID:
7961012
5.

Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.

Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S.

Laryngoscope. 2008 Aug;118(8):1417-21. doi: 10.1097/MLG.0b013e3181781791.

PMID:
18528306
6.

Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.

Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M.

Strahlenther Onkol. 2004 Feb;180(2):84-90.

PMID:
14762660
7.

Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.

Nishimura Y, Nagata Y, Okajima K, Mitsumori M, Hiraoka M, Masunaga S, Ono K, Shoji K, Kojima H.

Radiother Oncol. 1996 Sep;40(3):225-32.

PMID:
8940749
8.

T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.

Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):461-6. doi: 10.1016/j.ijrobp.2009.08.066. Epub 2010 Feb 12.

PMID:
20153124
9.

Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.

Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1378-86. Epub 2005 Aug 10.

PMID:
16095847
10.

Impact of radiation therapy fraction size on local control of early glottic carcinoma.

Yu E, Shenouda G, Beaudet MP, Black MJ.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):587-91.

PMID:
9112457
11.

The impact of treatment time and smoking on local control and complications in T1 glottic cancer.

van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H.

Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):247-55.

PMID:
9788401
12.

Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients.

Marshak G, Brenner B, Shvero J, Shapira J, Ophir D, Hochman I, Marshak G, Sulkes A, Rakowsky E.

Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1009-13.

PMID:
10192348
13.

Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.

Lee JH, Machtay M, McKenna MG, Weinstein GS, Markiewicz DA, Krisch RE, Kligerman MM.

Am J Otolaryngol. 2001 Jan-Feb;22(1):43-54. Review.

PMID:
11172214
14.

Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?

Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK.

Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):322-8.

PMID:
12527044
15.

Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.

Ricciardelli EJ, Weymuller EA Jr, Koh WJ, Austin-Seymour M, DeSautel MG, Laramore GE.

Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):737-42. Review.

PMID:
8018326
16.

High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors.

Gultekin M, Ozyar E, Cengiz M, Ozyigit G, Hayran M, Hosal S, Akyol F.

Head Neck. 2012 Jul;34(7):1009-14. doi: 10.1002/hed.21860. Epub 2011 Nov 2.

PMID:
22052787
17.

Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.

Canaday DJ, Regine WF, Mohiuddin M, Zollinger W, Machtay M, Lee J, Schultz D, Rudoltz MS.

Radiat Oncol Investig. 1999;7(1):42-8.

PMID:
10030623
18.

Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.

Sommat K, Yit NL, Kwok LL.

Laryngoscope. 2017 May;127(5):1061-1067. doi: 10.1002/lary.26067. Epub 2016 May 30.

PMID:
27237064
19.

Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases.

Le QT, Takamiya R, Shu HK, Smitt M, Singer M, Terris DJ, Fee WE, Goffinet DR, Fu KK.

Arch Otolaryngol Head Neck Surg. 2000 Nov;126(11):1305-12.

PMID:
11074826
20.

Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.

Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ.

Radiother Oncol. 2003 Aug;68(2):105-11.

PMID:
12972304

Supplemental Content

Support Center